2018 Q4 Form 10-K Financial Statement

#000156459020007549 Filed on February 28, 2020

View on sec.gov

Income Statement

Concept 2018 Q4 2017
Revenue $5.587M
YoY Change 140.68%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin
YoY Change
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses
YoY Change
Operating Profit $552.9K
YoY Change -113.08%
Interest Expense
YoY Change
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income
YoY Change
Income Tax
% Of Pretax Income
Net Earnings -$61.71M
YoY Change -323.57%
Net Earnings / Revenue -1104.39%
Basic Earnings Per Share
Diluted Earnings Per Share
COMMON SHARES
Basic Shares Outstanding
Diluted Shares Outstanding

Balance Sheet

Concept 2018 Q4 2017
SHORT-TERM ASSETS
Cash & Short-Term Investments
YoY Change
Cash & Equivalents
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets
YoY Change
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets
YoY Change
TOTAL ASSETS
Total Short-Term Assets
Total Long-Term Assets
Total Assets $516.4M
YoY Change -4.59%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable
YoY Change
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities
YoY Change
LONG-TERM LIABILITIES
Long-Term Debt
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities
Total Long-Term Liabilities
Total Liabilities $22.01M
YoY Change 159.61%
SHAREHOLDERS EQUITY
Retained Earnings
YoY Change
Common Stock
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $494.4M
YoY Change
Total Liabilities & Shareholders Equity $516.4M
YoY Change -4.59%

Cashflow Statement

Concept 2018 Q4 2017
OPERATING ACTIVITIES
Net Income -$61.71M
YoY Change -323.57%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities $246.1M
YoY Change -6.54%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid $538.7K
YoY Change
Common Stock Issuance & Retirement, Net $246.1M
YoY Change -21.94%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -246.1M
YoY Change -21.94%
NET CHANGE
Cash From Operating Activities 246.1M
Cash From Investing Activities
Cash From Financing Activities -246.1M
Net Change In Cash 0.000
YoY Change -100.0%
FREE CASH FLOW
Cash From Operating Activities $246.1M
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2019Q4 us-gaap Commissions Payable To Broker Dealers And Clearing Organizations
CommissionsPayableToBrokerDealersAndClearingOrganizations
4001
CY2019Q4 us-gaap General Partners Capital Account
GeneralPartnersCapitalAccount
1038
CY2019Q4 us-gaap Liabilities
Liabilities
11492930
CY2019Q4 us-gaap Limited Partners Capital Account
LimitedPartnersCapitalAccount
228316179
CY2019Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
239810147
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
228317217
CY2019Q4 us-gaap General Partners Capital Account Units Outstanding
GeneralPartnersCapitalAccountUnitsOutstanding
40
CY2019Q4 us-gaap Limited Partners Capital Account Units Outstanding
LimitedPartnersCapitalAccountUnitsOutstanding
8800000
CY2019Q4 us-gaap Net Asset Value Per Share
NetAssetValuePerShare
25.95
CY2019Q4 uup Market Value Per Share
MarketValuePerShare
25.98
CY2019Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2018Q4 us-gaap Financial Instruments Owned Us Government And Agency Obligations At Fair Value
FinancialInstrumentsOwnedUSGovernmentAndAgencyObligationsAtFairValue
409384745
CY2018Q4 us-gaap Investments In And Advances To Affiliates At Fair Value
InvestmentsInAndAdvancesToAffiliatesAtFairValue
102216801
CY2018Q4 us-gaap Dividends Receivable
DividendsReceivable
58722
CY2018Q4 us-gaap Assets
Assets
516365973
CY2019Q4 us-gaap Due To Related Parties Current And Noncurrent
DueToRelatedPartiesCurrentAndNoncurrent
153782
CY2019 us-gaap Unrealized Gain Loss On Marketable Securities Cost Method Investments And Other Investments
UnrealizedGainLossOnMarketableSecuritiesCostMethodInvestmentsAndOtherInvestments
2844263
CY2018 us-gaap Unrealized Gain Loss On Marketable Securities Cost Method Investments And Other Investments
UnrealizedGainLossOnMarketableSecuritiesCostMethodInvestmentsAndOtherInvestments
3612436
CY2017 us-gaap Unrealized Gain Loss On Marketable Securities Cost Method Investments And Other Investments
UnrealizedGainLossOnMarketableSecuritiesCostMethodInvestmentsAndOtherInvestments
-10293438
CY2018 us-gaap Investment Company Realized And Unrealized Gain Loss On Investment And Foreign Currency
InvestmentCompanyRealizedAndUnrealizedGainLossOnInvestmentAndForeignCurrency
33205794
CY2019 us-gaap Due To And From Broker Dealers And Clearing Organizations Disclosure
DueToAndFromBrokerDealersAndClearingOrganizationsDisclosure
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Note 5 - Deposits with Commodity Broker and Custodian</p> <p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Fund defines cash as cash held by the Custodian. There were no cash equivalents held by the Fund as of December 31, 2019 and 2018. </p> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Fund may deposit cash, United States Treasury Obligations, T-Bill ETFs and money market mutual funds with the Commodity Broker as margin, to the extent permissible under CFTC rules. The combination of the Fund’s deposits with its Commodity Broker of cash and United States Treasury Obligations and the unrealized profit or loss on open futures contracts represents the Fund’s overall equity in its broker trading account. To meet the Fund’s maintenance margin requirements, the Fund holds United States Treasury Obligations with the Commodity Broker. The Fund transfers cash to the Commodity Broker to satisfy variation margin requirements. The Fund earns interest on any excess cash deposited with the Commodity Broker and incurs interest expense on any deficit balance with the Commodity Broker. The Fund may deposit T-Bill ETFs and money market mutual funds with the Commodity Broker as margin, to the extent permissible under CFTC rules.</p> <p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The brokerage agreement with the Commodity Broker provides for the net settlement of all financial instruments covered by the agreement in the event of default or termination of any one contract. The Managing Owner will utilize any excess cash held at the Commodity Broker to offset any realized losses incurred in the currency futures contracts, if available. To the extent that any excess cash held at the Commodity Broker is not adequate to cover any realized losses, a portion of the United States Treasury Obligations and T-Bill ETFs, if any, on deposit with the Commodity Broker will be sold to make additional cash available. For financial reporting purposes, the Fund offsets financial assets and financial liabilities that are subject to legally enforceable netting arrangements.</p> <p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> The Fund’s remaining cash, United States Treasury Obligations, T-Bill ETFs and money market mutual fund holdings are on deposit with the Custodian. The Fund is permitted to temporarily carry a negative or overdrawn balance in its account with the Custodian. The Fund incurs interest expense on any overdraft balance with the Custodian. Such balances, if any at period-end, are shown on the Statements of Financial Condition under the payable caption <span style="font-style:italic;">Due to custodian</span>.</p>
CY2018Q4 uup Payable To Clearing Organizations
PayableToClearingOrganizations
1213618
CY2019Q4 uup Payable For Shares Redeemed
PayableForSharesRedeemed
10505574
CY2018Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2019 dei Document Annual Report
DocumentAnnualReport
true
CY2019 dei Document Transition Report
DocumentTransitionReport
false
CY2019 dei Entity File Number
EntityFileNumber
001-33314
CY2019 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
CY2019 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
87-0778082
CY2019 dei Entity Address Address Line1
EntityAddressAddressLine1
Invesco Capital Management LLC
CY2019 dei Entity Address Address Line2
EntityAddressAddressLine2
3500 Lacey Road
CY2019 dei Entity Address Address Line3
EntityAddressAddressLine3
Suite 700
CY2019 dei Entity Address City Or Town
EntityAddressCityOrTown
Downers Grove
CY2019 dei Entity Address State Or Province
EntityAddressStateOrProvince
IL
CY2019 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
60515
CY2019 dei City Area Code
CityAreaCode
800
CY2019 dei Local Phone Number
LocalPhoneNumber
83-0903
CY2019 dei Security12b Title
Security12bTitle
Common Units of Beneficial Interest
CY2019 dei Security Exchange Name
SecurityExchangeName
NYSEArca
CY2019 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2019Q4 us-gaap Assets
Assets
239810147
CY2019Q4 us-gaap Dividends Receivable
DividendsReceivable
28419
CY2019 uup Unrealized Gain Loss On Affiliated Investments
UnrealizedGainLossOnAffiliatedInvestments
75700
CY2019 us-gaap Realized Investment Gains Losses
RealizedInvestmentGainsLosses
5495926
CY2019 us-gaap Marketable Securities Unrealized Gain Loss
MarketableSecuritiesUnrealizedGainLoss
49369
CY2018 us-gaap Marketable Securities Unrealized Gain Loss
MarketableSecuritiesUnrealizedGainLoss
45626
CY2018 uup Unrealized Gain Loss On Affiliated Investments
UnrealizedGainLossOnAffiliatedInvestments
128690
CY2018 us-gaap Realized Investment Gains Losses
RealizedInvestmentGainsLosses
29593358
CY2017Q4 us-gaap Cash
Cash
0
CY2019Q4 us-gaap Investment Owned At Fair Value
InvestmentOwnedAtFairValue
229276654
CY2019Q4 us-gaap Financial Instruments Owned Us Government And Agency Obligations At Fair Value
FinancialInstrumentsOwnedUSGovernmentAndAgencyObligationsAtFairValue
123646647
CY2019Q4 us-gaap Investments In And Advances To Affiliates At Fair Value
InvestmentsInAndAdvancesToAffiliatesAtFairValue
105630007
CY2019Q4 us-gaap Cash
Cash
10505074
CY2018Q4 us-gaap Cash
Cash
4705705
CY2019 us-gaap Investment Company Realized And Unrealized Gain Loss On Investment And Foreign Currency
InvestmentCompanyRealizedAndUnrealizedGainLossOnInvestmentAndForeignCurrency
8340189
CY2018 us-gaap Net Income Loss
NetIncomeLoss
38849945
CY2017 us-gaap Operating Income Loss
OperatingIncomeLoss
552896
CY2017 us-gaap Investment Company Realized And Unrealized Gain Loss On Investment And Foreign Currency
InvestmentCompanyRealizedAndUnrealizedGainLossOnInvestmentAndForeignCurrency
-62258637
CY2017 us-gaap Net Income Loss
NetIncomeLoss
-61705741
CY2019 us-gaap Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
2719194
CY2018 us-gaap Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
3438120
CY2019 us-gaap Unrealized Gain Loss On Marketable Securities Cost Method Investments And Other Investments
UnrealizedGainLossOnMarketableSecuritiesCostMethodInvestmentsAndOtherInvestments
2844263
CY2019Q4 uup Payable To Clearing Organizations
PayableToClearingOrganizations
829573
CY2018Q4 uup Payable For Shares Redeemed
PayableForSharesRedeemed
20470746
CY2018Q4 us-gaap Due To Related Parties Current And Noncurrent
DueToRelatedPartiesCurrentAndNoncurrent
324363
CY2018Q4 us-gaap Commissions Payable To Broker Dealers And Clearing Organizations
CommissionsPayableToBrokerDealersAndClearingOrganizations
4654
CY2018Q4 us-gaap Liabilities
Liabilities
22013381
CY2018Q4 us-gaap General Partners Capital Account
GeneralPartnersCapitalAccount
1019
CY2018Q4 us-gaap Limited Partners Capital Account
LimitedPartnersCapitalAccount
494351573
CY2018Q4 us-gaap Stockholders Equity
StockholdersEquity
494352592
CY2018Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
516365973
CY2018Q4 us-gaap General Partners Capital Account Units Outstanding
GeneralPartnersCapitalAccountUnitsOutstanding
40
CY2018Q4 us-gaap Limited Partners Capital Account Units Outstanding
LimitedPartnersCapitalAccountUnitsOutstanding
19400000
CY2018Q4 us-gaap Net Asset Value Per Share
NetAssetValuePerShare
25.48
CY2018Q4 uup Market Value Per Share
MarketValuePerShare
25.47
CY2019Q4 us-gaap Good Faith And Margin Deposits With Broker Dealers
GoodFaithAndMarginDepositsWithBrokerDealers
8068540
CY2018Q4 us-gaap Good Faith And Margin Deposits With Broker Dealers
GoodFaithAndMarginDepositsWithBrokerDealers
10614400
CY2019 uup Operating Expenses Net
OperatingExpensesNet
2604464
CY2018 us-gaap Operating Income Loss
OperatingIncomeLoss
5644151
CY2017 us-gaap Marketable Securities Realized Gain Loss
MarketableSecuritiesRealizedGainLoss
-7094
CY2019 uup Net Realized Gain Loss On Capital Gain Distributions From Affiliated Investments
NetRealizedGainLossOnCapitalGainDistributionsFromAffiliatedInvestments
11446
CY2019 us-gaap Marketable Securities Realized Gain Loss
MarketableSecuritiesRealizedGainLoss
61775
CY2018 us-gaap Marketable Securities Realized Gain Loss
MarketableSecuritiesRealizedGainLoss
-26350
CY2019 us-gaap Gain Loss On Sale Of Investments
GainLossOnSaleOfInvestments
5422705
CY2019 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
201428538
CY2019 us-gaap Stock Redeemed Or Called During Period Value
StockRedeemedOrCalledDuringPeriodValue
475881973
CY2019 uup Stockholders Equity Period Increase Decrease Due To Share Transactions
StockholdersEquityPeriodIncreaseDecreaseDueToShareTransactions
-274453435
CY2019 us-gaap Partners Capital Account Return Of Capital
PartnersCapitalAccountReturnOfCapital
5050773
CY2019 us-gaap Operating Income Loss
OperatingIncomeLoss
5128644
CY2019 us-gaap Realized Gain Loss On Marketable Securities Cost Method Investments And Other Investments
RealizedGainLossOnMarketableSecuritiesCostMethodInvestmentsAndOtherInvestments
5495926
CY2017 us-gaap Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
-9961447
CY2017 uup Unrealized Gain Loss On Affiliated Investments
UnrealizedGainLossOnAffiliatedInvestments
-317334
CY2018Q4 us-gaap Stockholders Equity
StockholdersEquity
494352592
CY2019Q4 us-gaap Investment Owned Percent Of Net Assets
InvestmentOwnedPercentOfNetAssets
1.0042
CY2019 us-gaap Operating Income Loss
OperatingIncomeLoss
5128644
CY2019 us-gaap Investment Company Contractual Fee Waived
InvestmentCompanyContractualFeeWaived
102795
CY2018 uup Operating Expenses Net
OperatingExpensesNet
3998912
CY2017 us-gaap Realized Investment Gains Losses
RealizedInvestmentGainsLosses
-51965199
CY2018 us-gaap Gain Loss On Sale Of Investments
GainLossOnSaleOfInvestments
29619708
CY2017 us-gaap Gain Loss On Sale Of Investments
GainLossOnSaleOfInvestments
-51958105
CY2017 us-gaap Net Income Loss
NetIncomeLoss
-61705741
CY2017 us-gaap Marketable Securities Unrealized Gain Loss
MarketableSecuritiesUnrealizedGainLoss
-14657
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
228317217
CY2018 uup Unrealized Gain Loss On Marketable Securities And Affiliated Investments
UnrealizedGainLossOnMarketableSecuritiesAndAffiliatedInvestments
174316
CY2017 uup Unrealized Gain Loss On Marketable Securities And Affiliated Investments
UnrealizedGainLossOnMarketableSecuritiesAndAffiliatedInvestments
-331991
CY2019 uup Increase Decrease In Variation Margin
IncreaseDecreaseInVariationMargin
384045
CY2018 uup Increase Decrease In Variation Margin
IncreaseDecreaseInVariationMargin
1561281
CY2017 uup Increase Decrease In Variation Margin
IncreaseDecreaseInVariationMargin
739851
CY2019 us-gaap Increase Decrease In Dividends Receivable
IncreaseDecreaseInDividendsReceivable
-30303
CY2018 us-gaap Increase Decrease In Dividends Receivable
IncreaseDecreaseInDividendsReceivable
36013
CY2017 us-gaap Increase Decrease In Dividends Receivable
IncreaseDecreaseInDividendsReceivable
5890
CY2019 us-gaap Increase Decrease In Accounts Payable Related Parties
IncreaseDecreaseInAccountsPayableRelatedParties
-170581
CY2018 us-gaap Increase Decrease In Accounts Payable Related Parties
IncreaseDecreaseInAccountsPayableRelatedParties
-36684
CY2017 us-gaap Increase Decrease In Accounts Payable Related Parties
IncreaseDecreaseInAccountsPayableRelatedParties
-171711
CY2019 us-gaap Increase Decrease In Payables To Broker Dealers
IncreaseDecreaseInPayablesToBrokerDealers
-653
CY2018 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
406980619
CY2018 us-gaap Stock Redeemed Or Called During Period Value
StockRedeemedOrCalledDuringPeriodValue
478633142
CY2018 uup Stockholders Equity Period Increase Decrease Due To Share Transactions
StockholdersEquityPeriodIncreaseDecreaseDueToShareTransactions
-71652523
CY2018 us-gaap Partners Capital Account Return Of Capital
PartnersCapitalAccountReturnOfCapital
5572383
CY2017 us-gaap Partners Capital Account Return Of Capital
PartnersCapitalAccountReturnOfCapital
538669
CY2017 us-gaap Operating Income Loss
OperatingIncomeLoss
552896
CY2017 us-gaap Realized Gain Loss On Marketable Securities Cost Method Investments And Other Investments
RealizedGainLossOnMarketableSecuritiesCostMethodInvestmentsAndOtherInvestments
-51965199
CY2017 us-gaap Unrealized Gain Loss On Marketable Securities Cost Method Investments And Other Investments
UnrealizedGainLossOnMarketableSecuritiesCostMethodInvestmentsAndOtherInvestments
-10293438
CY2017Q4 us-gaap Stockholders Equity
StockholdersEquity
532727553
CY2019 us-gaap Net Income Loss
NetIncomeLoss
13468833
CY2018 us-gaap Net Income Loss
NetIncomeLoss
38849945
CY2017 us-gaap Net Income Loss
NetIncomeLoss
-61705741
CY2019 us-gaap Payments For Purchase Of Securities Operating Activities
PaymentsForPurchaseOfSecuritiesOperatingActivities
915211456
CY2018 us-gaap Payments For Purchase Of Securities Operating Activities
PaymentsForPurchaseOfSecuritiesOperatingActivities
1054042847
CY2019 us-gaap Proceeds From Sale Of Securities Operating Activities
ProceedsFromSaleOfSecuritiesOperatingActivities
1206589525
CY2019 uup Cost Of Affiliated Investments Purchased
CostOfAffiliatedInvestmentsPurchased
766376656
CY2018 uup Cost Of Affiliated Investments Purchased
CostOfAffiliatedInvestmentsPurchased
722071670
CY2017 uup Cost Of Affiliated Investments Purchased
CostOfAffiliatedInvestmentsPurchased
1045572170
CY2019 uup Proceeds From Affiliated Investments Sold
ProceedsFromAffiliatedInvestmentsSold
763039150
CY2018 uup Proceeds From Affiliated Investments Sold
ProceedsFromAffiliatedInvestmentsSold
700995257
CY2017 uup Proceeds From Affiliated Investments Sold
ProceedsFromAffiliatedInvestmentsSold
968029450
CY2019 us-gaap Depreciation Amortization And Accretion Net
DepreciationAmortizationAndAccretionNet
-5528827
CY2018 us-gaap Depreciation Amortization And Accretion Net
DepreciationAmortizationAndAccretionNet
-7771473
CY2017 us-gaap Depreciation Amortization And Accretion Net
DepreciationAmortizationAndAccretionNet
-4793315
CY2019 us-gaap Marketable Securities Realized Gain Loss
MarketableSecuritiesRealizedGainLoss
61775
CY2018 us-gaap Marketable Securities Realized Gain Loss
MarketableSecuritiesRealizedGainLoss
-26350
CY2017 us-gaap Marketable Securities Realized Gain Loss
MarketableSecuritiesRealizedGainLoss
-7094
CY2019 uup Unrealized Gain Loss On Marketable Securities And Affiliated Investments
UnrealizedGainLossOnMarketableSecuritiesAndAffiliatedInvestments
125069
CY2018 us-gaap Increase Decrease In Payables To Broker Dealers
IncreaseDecreaseInPayablesToBrokerDealers
156
CY2017 us-gaap Increase Decrease In Payables To Broker Dealers
IncreaseDecreaseInPayablesToBrokerDealers
302
CY2019 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
295268749
CY2017Q4 us-gaap Stockholders Equity
StockholdersEquity
532727553
CY2018 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
66798780
CY2017 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
246138030
CY2019 us-gaap Payments Of Dividends
PaymentsOfDividends
5050773
CY2019 uup Minimum Number Of Creation Units Of Shares That Can Be Purchased
MinimumNumberOfCreationUnitsOfSharesThatCanBePurchased
1
CY2019 uup Number Of Shares Issued Per Creation Unit
NumberOfSharesIssuedPerCreationUnit
200000
CY2019 uup Minimum Number Of Creation Units Of Shares That Can Be Redeemed
MinimumNumberOfCreationUnitsOfSharesThatCanBeRedeemed
1
CY2019 uup Number Of Shares Issued Per Creation Unit
NumberOfSharesIssuedPerCreationUnit
200000
CY2018 us-gaap Payments Of Dividends
PaymentsOfDividends
5572383
CY2017 us-gaap Payments Of Dividends
PaymentsOfDividends
538669
CY2019 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
201428538
CY2018 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
406980619
CY2017 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
392781258
CY2019 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
485847145
CY2018 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
462961642
CY2017 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
638919288
CY2018 uup Increase Decrease In Payable For Amount Due To Custodian
IncreaseDecreaseInPayableForAmountDueToCustodian
-539669
CY2017 uup Increase Decrease In Payable For Amount Due To Custodian
IncreaseDecreaseInPayableForAmountDueToCustodian
538669
CY2019 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-289469380
CY2019 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
5799369
CY2018 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
4705705
CY2018Q4 us-gaap Cash
Cash
4705705
CY2017Q4 us-gaap Cash
Cash
0
CY2016Q4 us-gaap Cash
Cash
0
CY2019Q4 us-gaap Cash
Cash
10505074
CY2018Q4 us-gaap Cash
Cash
4705705
CY2019 us-gaap Interest Paid Net
InterestPaidNet
10911
CY2019 us-gaap Dividend Payable Date To Be Paid Day Month And Year
DividendPayableDateToBePaidDayMonthAndYear
2019-12-31
CY2019 us-gaap Dividends Payable Date Of Record Day Month And Year
DividendsPayableDateOfRecordDayMonthAndYear
2019-12-24
CY2019 us-gaap Use Of Estimates
UseOfEstimates
<p style="margin-top:6pt;margin-bottom:0pt;margin-left:3.33%;text-indent:-3.33%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">B.  Accounting Estimates</p> <p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates by a significant amount. In addition, the </p> <p style="margin-top:6pt;margin-bottom:0pt;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Fund monitors for material events or transactions that may occur or become known after the period-end date and before the date the financial statements are </span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">issued</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">.</span></p>
CY2017 uup Average Charges Paid To Broker Per Round Turn Trade Maximum
AverageChargesPaidToBrokerPerRoundTurnTradeMaximum
6.00
CY2017 us-gaap Investment Company Investment Income Loss Per Share
InvestmentCompanyInvestmentIncomeLossPerShare
0.02
CY2019 us-gaap Investment Company Investment Income Loss From Operations Per Share
InvestmentCompanyInvestmentIncomeLossFromOperationsPerShare
1.00
CY2018Q4 us-gaap Net Asset Value Per Share
NetAssetValuePerShare
25.48
CY2017Q4 us-gaap Net Asset Value Per Share
NetAssetValuePerShare
24.00
CY2016Q4 us-gaap Net Asset Value Per Share
NetAssetValuePerShare
26.43
CY2019 us-gaap Investment Company Gain Loss On Investment Per Share
InvestmentCompanyGainLossOnInvestmentPerShare
0.61
CY2018 us-gaap Investment Company Gain Loss On Investment Per Share
InvestmentCompanyGainLossOnInvestmentPerShare
1.50
CY2017 us-gaap Investment Company Gain Loss On Investment Per Share
InvestmentCompanyGainLossOnInvestmentPerShare
-2.43
CY2019 us-gaap Investment Company Investment Income Loss Per Share
InvestmentCompanyInvestmentIncomeLossPerShare
0.39
CY2018 us-gaap Investment Company Investment Income Loss Per Share
InvestmentCompanyInvestmentIncomeLossPerShare
0.26
CY2018 us-gaap Investment Company Investment Income Loss From Operations Per Share
InvestmentCompanyInvestmentIncomeLossFromOperationsPerShare
1.76
CY2017 us-gaap Investment Company Investment Income Loss From Operations Per Share
InvestmentCompanyInvestmentIncomeLossFromOperationsPerShare
-2.41
CY2019 us-gaap Investment Company Tax Return Of Capital Distribution Per Share
InvestmentCompanyTaxReturnOfCapitalDistributionPerShare
-0.53
CY2018 us-gaap Investment Company Tax Return Of Capital Distribution Per Share
InvestmentCompanyTaxReturnOfCapitalDistributionPerShare
-0.28
CY2017 us-gaap Investment Company Tax Return Of Capital Distribution Per Share
InvestmentCompanyTaxReturnOfCapitalDistributionPerShare
-0.02
CY2018Q4 uup Market Value Per Share
MarketValuePerShare
25.47
CY2017Q4 uup Market Value Per Share
MarketValuePerShare
24.04
CY2016Q4 uup Market Value Per Share
MarketValuePerShare
26.45
CY2019Q4 uup Market Value Per Share
MarketValuePerShare
25.98
CY2018Q4 uup Market Value Per Share
MarketValuePerShare
25.47
CY2017Q4 uup Market Value Per Share
MarketValuePerShare
24.04
CY2019 us-gaap Investment Company Investment Income Loss Ratio
InvestmentCompanyInvestmentIncomeLossRatio
0.0147
CY2018 us-gaap Investment Company Investment Income Loss Ratio
InvestmentCompanyInvestmentIncomeLossRatio
0.0107
CY2017 us-gaap Investment Company Investment Income Loss Ratio
InvestmentCompanyInvestmentIncomeLossRatio
0.0008
CY2019 us-gaap Investment Company Expense Ratio Including Voluntary Fee Waiver
InvestmentCompanyExpenseRatioIncludingVoluntaryFeeWaiver
0.0075
CY2018 us-gaap Investment Company Expense Ratio Including Voluntary Fee Waiver
InvestmentCompanyExpenseRatioIncludingVoluntaryFeeWaiver
0.0076
CY2017 us-gaap Investment Company Expense Ratio Including Voluntary Fee Waiver
InvestmentCompanyExpenseRatioIncludingVoluntaryFeeWaiver
0.0076
CY2019 uup Average Net Assets To Expenses Prior To Waivers
AverageNetAssetsToExpensesPriorToWaivers
0.0078
CY2018 uup Average Net Assets To Expenses Prior To Waivers
AverageNetAssetsToExpensesPriorToWaivers
0.0078
CY2017 uup Average Net Assets To Expenses Prior To Waivers
AverageNetAssetsToExpensesPriorToWaivers
0.0077
CY2019 us-gaap Investment Company Total Return
InvestmentCompanyTotalReturn
0.0384
CY2018 us-gaap Investment Company Total Return
InvestmentCompanyTotalReturn
0.0731
CY2017 us-gaap Investment Company Total Return
InvestmentCompanyTotalReturn
-0.0911
CY2019 uup Return At Market Value
ReturnAtMarketValue
0.0405
CY2018 uup Return At Market Value
ReturnAtMarketValue
0.0709
CY2017 uup Return At Market Value
ReturnAtMarketValue
-0.0903
CY2018Q4 us-gaap Net Asset Value Per Share
NetAssetValuePerShare
25.48
CY2017Q4 us-gaap Net Asset Value Per Share
NetAssetValuePerShare
24.00

Files In Submission

Name View Source Status
0001564590-20-007549-index-headers.html Edgar Link pending
0001564590-20-007549-index.html Edgar Link pending
0001564590-20-007549.txt Edgar Link pending
0001564590-20-007549-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
gb5z20blx1ce000001.jpg Edgar Link pending
gb5z20blx1ce000002.jpg Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
uup-10k_20191231.htm Edgar Link pending
uup-10k_20191231_htm.xml Edgar Link completed
uup-20191231.xsd Edgar Link pending
uup-20191231_cal.xml Edgar Link unprocessable
uup-20191231_def.xml Edgar Link unprocessable
uup-20191231_lab.xml Edgar Link unprocessable
uup-20191231_pre.xml Edgar Link unprocessable
uup-ex231_786.htm Edgar Link pending
uup-ex311_11.htm Edgar Link pending
uup-ex312_10.htm Edgar Link pending
uup-ex313_7.htm Edgar Link pending
uup-ex314_12.htm Edgar Link pending
uup-ex321_9.htm Edgar Link pending
uup-ex322_8.htm Edgar Link pending
uup-ex323_13.htm Edgar Link pending
uup-ex324_6.htm Edgar Link pending
uup-ex43_404.htm Edgar Link pending